Bladder Diary for Diagnosing Bladder Oversensitivity
Bladder Diary Can be a Good Surrogate of Diagnosing Bladder Oversensitivity
Bladder Diary Can be a Good Surrogate of Diagnosing Bladder Oversensitivity
Sponsor study identifier
observational
3,960
1 country
1
Study Start
July 1, 2009
Actual (reported)Primary Completion
December 31, 2020
Actual (reported)Study Completion
December 31, 2020
Actual (reported)Urodynamic study is an invasive procedure and applied for diagnosis of bladder oversensitivity. Bladder diary is a non-invasive measurement. The aim of this study was to elucidate whether bladder diary is a good surrogate for diagnosing bladder oversensitivity.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1, 2009
Actual (reported)December 31, 2020
Actual (reported)December 31, 2020
Actual (reported)July 20, 2021
Actual (reported)July 28, 2021
Actual (reported)Correlation between parameters
Correlation between 3-day bladder diary and urodynamic parameters
July 2009 to December 2020
Women with lower urinary tract symptoms without cystocele were included.
A three-day bladder diary for recording voiding-flow pattern of a women
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All women with lower urinary tract symptoms but without cystocele who visited the urogynecological department of a medical center for urodynamic evaluation were included.
National Taiwan University Hospital
Taipei, 100, Taiwan
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN; International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4-20. doi: 10.1002/nau.20798.
Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, Aiyer LP. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009 Apr;103 Suppl 3:4-11. doi: 10.1111/j.1464-410X.2009.08371.x.
Ho-Hsiung Lin, PhD
National Taiwan University Hospital
3,960 participants (actual enrollment reported by the registry).
First Submitted
July 20, 2021
First Posted
July 28, 2021
Study Start
July 1, 2009
Actual (reported)Contact the study team to confirm eligibility.
Hsiao SM, Lin HH. Medical treatment of female overactive bladder syndrome and treatment-related effects. J Formos Med Assoc. 2018 Oct;117(10):871-878. doi: 10.1016/j.jfma.2018.01.011. Epub 2018 Feb 15.
Hsiao SM, Su TC, Chen CH, Chang TC, Lin HH. Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects. Maturitas. 2014 Sep;79(1):65-9. doi: 10.1016/j.maturitas.2014.06.001. Epub 2014 Jun 20.
Hsiao SM, Liao SC, Chen CH, Chang TC, Lin HH. Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effects. Maturitas. 2014 Dec;79(4):428-34. doi: 10.1016/j.maturitas.2014.08.009. Epub 2014 Sep 3.
Primary Completion
December 31, 2020
Actual (reported)Study Completion
December 31, 2020
Actual (reported)Last Updated
July 28, 2021
Record last verified: 2021-07
Individual participant data is available under reasonable request
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: